Kaitlib Fe Kit
Product Images NDC 68180-903

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Kaitlib Fe (NDC 68180-903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure1 (4219be8d 43de 44b7 8581 2720bee42ab6 01)

Chemical structure diagram depicting the molecular structure of the active ingredient in Kaitlib Fe by Lupin Pharmaceuticals, Inc. The diagram shows rings, hydroxyl groups, and other chemical bonds typical of a complex organic molecule.*

FDA Label Image

Structure2 (4219be8d 43de 44b7 8581 2720bee42ab6 02)

Chemical structure diagram showing a steroid-like molecule with multiple rings, labeled with hydrogen (H), methyl (CH3), hydroxyl (OH), and ketone groups, as well as an alkyne side chain. This represents the chemical structure of the active ingredient associated with Kaitlib Fe.*

FDA Label Image

Figure1 (4219be8d 43de 44b7 8581 2720bee42ab6 03)

An illustration showing a vertical effectiveness scale of birth control methods based on pregnancies per 100 women in one year. It categorizes methods from fewer pregnancies at the top (implants, injections, intrauterine devices, sterilization) to more pregnancies toward the bottom (no birth control), with intermediate groups including birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, and methods like withdrawal and spermicides.*

FDA Label Image

Figure2 (4219be8d 43de 44b7 8581 2720bee42ab6 04)

Illustration showing a weekly day label strip for Kaitlib Fe oral tablets used to track daily pill intake across four weeks, starting from Sunday. It includes circular markers for each day of the week arranged in rows labeled Week 1 to Week 4 and includes guidance for starting on a day other than Sunday. The right edge notes a monthly self breast exam reminder.*

FDA Label Image

Blister (4219be8d 43de 44b7 8581 2720bee42ab6 05)

Packaging label for Kaitlib Fe chewable tablets containing norethindrone 0.8 mg, ethinyl estradiol 0.025 mg, and ferrous fumarate. The label shows the product name, active ingredient strengths, storage instructions, manufacturer Lupin Limited (India), and distributor Lupin Pharmaceuticals, Inc. (Baltimore, MD). It includes a weekly tablet intake calendar for four weeks with days of the week and monthly self breast exam reminder.*

FDA Label Image

Pouch (4219be8d 43de 44b7 8581 2720bee42ab6 06)

Packaging label for Kaitlib Fe chewable tablets containing norethindrone 0.8 mg, ethinyl estradiol 0.025 mg, and ferrous fumarate. The label states it is a prescription product, comes as 1 blister of 28 tablets, and is distributed by Lupin Pharmaceuticals, Inc. The label includes storage instructions and a statement that it does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Carton (4219be8d 43de 44b7 8581 2720bee42ab6 07)

Packaging label for Kaitlib Fe tablets by Lupin Pharmaceuticals, Inc. Contains norethindrone and ethinyl estradiol chewable tablets (0.8 mg/0.025 mg) and ferrous fumarate chewable tablets. Includes 3 blisters of 28 tablets each. The label states the product is Rx only and provides distribution and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.